Cited by 3,165Cardiovascular Function and Risk FactorsCardiovascular Disease and AdiposityDiabetes, Cardiovascular Risks, and Lipoproteins

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism

Poirier, Paul, Giles, Thomas D., Bray, George A., Hong, Yuling, Stern, Judith S., Pi-Sunyer, F. Xavier, Eckel, Robert H.·2006·Circulation

Abstract

Obesity is becoming a global epidemic in both children and adults. It is associated with numerous comorbidities such as cardiovascular diseases (CVD), type 2 diabetes, hypertension, certain cancers, and sleep apnea/sleep-disordered breathing. In fact, obesity is an independent risk factor for CVD, and CVD risks have also been documented in obese children. Obesity is associated with an increased risk of morbidity and mortality as well as reduced life expectancy. Health service use and medical costs associated with obesity and related diseases have risen dramatically and are expected to continue to rise. Besides an altered metabolic profile, a variety of adaptations/alterations in cardiac structure and function occur in the individual as adipose tissue accumulates in excess amounts, even in the absence of comorbidities. Hence, obesity may affect the heart through its influence on known risk factors such as dyslipidemia, hypertension, glucose intolerance, inflammatory markers, obstructive sleep apnea/hypoventilation, and the prothrombotic state, in addition to as-yet-unrecognized mechanisms. On the whole, overweight and obesity predispose to or are associated with numerous cardiac complications such as coronary heart disease, heart failure, and sudden death because of their impact on the cardiovascular system. The pathophysiology of these entities that are linked to obesity will be discussed. However, the cardiovascular clinical evaluation of obese patients may be limited because of the morphology of the individual. In this statement, we review the available evidence of the impact of obesity on CVD with emphasis on the evaluation of cardiac structure and function in obese patients and the effect of weight loss on the cardiovascular system.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.106.171016

Cites

353 of 353 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Better weight-loss treatment and maintenance can improve several obesity-related CHD risk factors and help lower the prevalence of the second most preventable cause of death.

    “Improving weight loss treatment and maintenance can improve several of the obesity-related risk factors for CHD (e.g., insulin resistance, type 2 diabetes) and help reduce the prevalence of the second most preventable cause of death today [5–7].”
  • Obesity is becoming a worldwide epidemic in both children and adults.

    “Obesity is becoming a worldwide epidemic in both children and adults.370”
  • Starvation, very-low-calorie diets, liquid protein diets, and obesity surgeries are associated with QTc prolongation and increased risk of malignant dysrhythmias, and various pharmacologic agents have limited efficacy or considerable toxicity.

    “Certainly, starvation, very-low-calorie diets, liquid protein diets, and obesity surgeries have been associated with prolongation of the QTc interval and increased risk of malignant dysrhythmias (1), and various pharmacologic agents have either limited efficacy or considerable toxicity (70 -72).”

    From Obesity and Cardiovascular Disease (2009) · cites this paper as [1]

  • For each 1-unit increase in BMI, the risk of ischemic stroke increases by 4% and the risk of hemorrhagic stroke increases by 6%.

    “In fact, for each 1-U increase in BMI, there was an increase of 4% in the risk of ischemic stroke and 6% for hemorrhagic stroke (1,53).”

    From Obesity and Cardiovascular Disease (2009) · cites this paper as [1]

  • The adipocyte acts as an endocrine organ and plays a substantial role in the pathogenesis and complications of obesity.

    “The adipocyte acts as an endocrine organ, and plays a substantial role in the pathogenesis and complications of obesity (1,10).”

    From Obesity and Cardiovascular Disease (2009) · cites this paper as [1]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 2

  1. Eckel RH, York DA, Rossner S, Hubbard V, Caterson I, St Jeor ST, Hayman LL, Mullis RM, Blair SN; American Heart Association. Pre- vention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation. 2004;110: 2968 -2975.
  2. Cheyne J. A case of apoplexy in which the fleshy part of the heart was converted into fat. Dublin Hosp Rep. 1818;2:216 -223.

Cited by

Sorted by citations

Authors
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H.
Affiliations
American Heart Association (US)
Venue
Circulation
Published
2006-02-14
Volume
113
Issue
6
Pages
898-918
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2101701509
Cited by
3,165
References
353
Citations by year
2026: 57 · 2025: 87 · 2024: 96 · 2023: 119 · 2022: 179 · 2021: 211 · 2020: 211 · 2019: 171 · 2018: 137 · 2017: 172 · 2016: 171 · 2015: 168 · 2014: 208 · 2013: 203 · 2012: 197
FWCI
71.01
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
American Heart Association
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
obesity, cardiovascular disease, obesity pathophysiology, weight loss, cardiac structure and function, coronary artery disease, heart failure, sudden cardiac death, dyslipidemia, hypertension, type 2 diabetes, obstructive sleep apnea, hypercoagulability, childhood obesity, cardiovascular risk factors
MeSH terms
American Heart Association, Cardiovascular Diseases, Humans, Obesity, Weight Loss

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review